Search Results

250 articles with title/keywords/abstract containing Randomised-controlled-trials

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
modify search
Display per page 

Health policy decisions require RCT and observational data

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 572, 2009-02-21 , pp. 2-2(1)

Publisher: Adis International

OROS hydromorphone vs ER oxycodone: a close call in OA

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 567, 2008-11-29 , pp. 13-13(1)

Publisher: Adis International

Escitalopram saves compared with duloxetine in MDD

Source: Inpharma, Volume 1, Number 1661, 2008-10-25 , pp. 4-4(1)

Publisher: Adis International

Escitalopram saves compared with duloxetine in MDD

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 565, 2008-11-01 , pp. 4-4(1)

Publisher: Adis International

OROS hydromorphone vs ER oxycodone: a close call in OA

Source: Inpharma, Volume 1, Number 1662, 2008-11-01 , pp. 4-4(1)

Publisher: Adis International

Can I make an observation?

Source: Inpharma, Volume 1, Number 1618, 2007-12-15 , pp. 8-8(1)

Publisher: Adis International

Clinical trials overestimate real-world anti-TNF efficacy in RA?

Source: Inpharma, Volume 1, Number 1618, 2007-12-15 , pp. 13-13(1)

Publisher: Adis International

Roflumilast of value in very severe COPD

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 535, 2007-08-25 , pp. 10-10(1)

Publisher: Adis International

Roflumilast of value in very severe COPD

Source: Inpharma, Volume 1, Number 1602, 2007-08-25 , pp. 6-6(1)

Publisher: Adis International

Pharmacist-led management increases cost of CHD

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 530, 2007-06-16 , pp. 6-6(1)

Publisher: Adis International

Lack of comparative trials makes new drugs a random affair

Source: Inpharma, Volume 1, Number 1579, 2007-03-17 , pp. 3-3(1)

Publisher: Adis International

When the evidence is strong enough without randomisation

Source: Inpharma, Volume 1, Number 1576, 2007-02-24 , pp. 3-3(1)

Publisher: Adis International

No advantages to CBT in benzodiazepine tapering strategies

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 508, 2006-07-29 , pp. 6-6(1)

Publisher: Adis International

Budesonide/formoterol adjustable dosing cost saving in asthma

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 482, 2005-07-16 , pp. 5-5(1)

Publisher: Adis International

Budesonide/formoterol adjustable dosing cost saving in asthma

Source: Inpharma, Volume 1, Number 1496, 2005-07-16 , pp. 4-4(1)

Publisher: Adis International

The WHO supports global registration of trials

Source: Inpharma, Volume 1, Number 1436, 2004-05-08 , pp. 2-2(1)

Publisher: Adis International

WHO-approved randomised controlled trials (RCTs) will soon be available free on the Internet

Source: Inpharma, Volume 1, Number 1434, 2004 , pp. 3-3(1)

Publisher: Adis International

Improving safety reporting in randomised trials

Source: Reactions, Volume 1, Number 896, 2002 , pp. 2-2(1)

Publisher: Adis International

Omeprazole and ranitidine: equivalent costs in GORD

Source: Inpharma, Volume 1, Number 1220, 2000 , pp. 7-7(1)

Publisher: Adis International

Fluticasone propionate better value than flunisolide in asthma

Source: Inpharma, Volume 1, Number 1220, 2000 , pp. 7-7(1)

Publisher: Adis International

modify search
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A